BARNES-JEWISH HOSPITAL
WASHINGTON UNIVERSITY SCHOOL OF MEDICINE
About Us
News & Events
Maps & Locations
Contact Us
Google Search
PATIENT AND VISITOR INFORMATION
TREATMENT PROGRAMS
PREVENTION AND SCREENING
RESEARCH
HOW TO HELP
FOR HEALTH PROFESSIONALS
Go back to:
Home
Treatment Programs
Types of Cancer
Clinical Trial Search Results
Share
Esophageal Cancer
NCI Information
Clinical Trials
Support Groups
Effects of Treatment
Podcast
Treatment Team
NEW SEARCH
RETURN TO SEARCH RESULTS
Number:
RTOG 1010
Principal Investigator:
Robinson, Clifford
Title:
A Phase III Trial Evaluating the Addition of Trastuzumab to Trimodality Treatment of Her2-Overexpressing Esophageal Adenocarcinoma
Phase:
III
Disease Site:
Esophagus
Participating Site(s):
Main Campus
Map and Directions
Contact:
800-600-3606 or
info@ccadmin.wustl.edu
Description:
This study is being done to compare the effects, good and/or bad, of the addition of trastuzumab to standard chemotherapy, radiation, and surgery for patients with HER2 positive esophageal cancer.
More Information:
(Links will take you off this web site)
ClinicalTrials.gov Entry
Internal Protocol Documents (requires Siteman administrative database password)